These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35041121)

  • 1. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
    Usman A; Bliden KP; Cho A; Walia N; Jerjian C; Singh A; Kundan P; Duhan S; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2022 Feb; 53(2):363-371. PubMed ID: 35041121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
    Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
    Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
    Lukito AA; Pranata R; Henrina J; Lim MA; Lawrensia S; Suastika K
    Diabetes Metab Syndr; 2020; 14(6):2177-2183. PubMed ID: 33395778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
    Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
    Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.
    Lohia P; Kapur S; Benjaram S; Cantor Z; Mahabadi N; Mir T; Badr MS
    Cardiovasc Diabetol; 2021 Jul; 20(1):140. PubMed ID: 34246277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
    BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
    Scheen AJ
    Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis.
    Ganesh A; Randall MD
    Br J Clin Pharmacol; 2022 Jun; 88(6):2642-2656. PubMed ID: 35122284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.
    Farah R; Shurtz-Swirski R; Lapin O
    Cardiovasc Diabetol; 2008 Jun; 7():20. PubMed ID: 18570678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease.
    Ho TW; Huang CT; Tsai YJ; Lien AS; Lai F; Yu CJ
    Respir Res; 2019 Apr; 20(1):69. PubMed ID: 30953517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Is Associated with Improved Survival and Decreased Cardiac Events with No Impact on Patency and Limb Salvage after Revascularization for Peripheral Arterial Disease.
    Khan SZ; Rivero M; Nader ND; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
    Ann Vasc Surg; 2019 Feb; 55():63-77. PubMed ID: 30081159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.
    Bishwakarma R; Zhang W; Lin YL; Kuo YF; Cardenas VJ; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():793-800. PubMed ID: 29551895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.